These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 33929683)

  • 21. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
    Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
    Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Putting the Brakes on Accelerated Cognitive Decline in Alzheimer's Disease with Epileptic Activity.
    Vossel K
    J Alzheimers Dis; 2023; 94(3):1075-1077. PubMed ID: 37522212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low brain ascorbic acid increases susceptibility to seizures in mouse models of decreased brain ascorbic acid transport and Alzheimer's disease.
    Warner TA; Kang JQ; Kennard JA; Harrison FE
    Epilepsy Res; 2015 Feb; 110():20-5. PubMed ID: 25616451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of Alzheimer's disease.
    Alonso Vilatela ME; López-López M; Yescas-Gómez P
    Arch Med Res; 2012 Nov; 43(8):622-31. PubMed ID: 23142261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alzheimer disease and epilepsy].
    Teplyshova AM; Datieva VK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10. Vyp. 2):23-29. PubMed ID: 34870910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic analyses of early-onset Alzheimer's disease using next generation sequencing.
    Giau VV; Bagyinszky E; Yang YS; Youn YC; An SSA; Kim SY
    Sci Rep; 2019 Jun; 9(1):8368. PubMed ID: 31182772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel presenilin mutations within Moroccan patients with Early-Onset Alzheimer's Disease.
    El Kadmiri N; Zaid N; Zaid Y; Tadevosyan A; Hachem A; Dubé MP; Hamzi K; El Moutawakil B; Slassi I; Nadifi S
    Neuroscience; 2014 Jun; 269():215-22. PubMed ID: 24704512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosing epileptic seizures in patients with Alzheimer's disease and deciding on the appropriate treatment plan.
    Brigo F; Lattanzi S
    Expert Rev Neurother; 2024 Apr; 24(4):361-370. PubMed ID: 38426448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
    Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Genetics of Early- and Late-Onset Alzheimer's Disease.
    Uddin MS; Hasana S; Hossain MF; Islam MS; Behl T; Perveen A; Hafeez A; Ashraf GM
    Curr Gene Ther; 2021; 21(1):43-52. PubMed ID: 33231156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seizures and epileptiform activity in the early stages of Alzheimer disease.
    Vossel KA; Beagle AJ; Rabinovici GD; Shu H; Lee SE; Naasan G; Hegde M; Cornes SB; Henry ML; Nelson AB; Seeley WW; Geschwind MD; Gorno-Tempini ML; Shih T; Kirsch HE; Garcia PA; Miller BL; Mucke L
    JAMA Neurol; 2013 Sep; 70(9):1158-66. PubMed ID: 23835471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer's Disease Field-An Opinion.
    Twyman RE
    Neurochem Res; 2017 Jul; 42(7):2099-2115. PubMed ID: 28589521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach?
    Löscher W
    Neurochem Res; 2017 Jul; 42(7):1926-1938. PubMed ID: 27502939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy.
    Del Pozo A; Lehmann L; Knox KM; Barker-Haliski M
    Front Neurol; 2022; 13():833624. PubMed ID: 35572927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of epileptiform activity by valproic acid in a mouse model of Alzheimer's disease is not long-lasting after treatment discontinuation.
    Ziyatdinova S; Viswanathan J; Hiltunen M; Tanila H; Pitkänen A
    Epilepsy Res; 2015 May; 112():43-55. PubMed ID: 25847338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer's disease.
    Cretin B
    Expert Opin Pharmacother; 2018 Aug; 19(11):1201-1209. PubMed ID: 30009650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epileptic Seizures in Alzheimer's Disease: What Are the Implications of SANAD II?
    Larner AJ; Marson AG
    J Alzheimers Dis; 2022; 85(2):527-529. PubMed ID: 34842191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review of the Familial Alzheimer's Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1.
    Jiang H; Jayadev S; Lardelli M; Newman M
    J Alzheimers Dis; 2018; 66(4):1323-1339. PubMed ID: 30412492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2.
    Hsu S; Pimenova AA; Hayes K; Villa JA; Rosene MJ; Jere M; Goate AM; Karch CM
    Neurobiol Dis; 2020 Jun; 139():104817. PubMed ID: 32087291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seizures in Alzheimer's disease are highly recurrent and associated with a poor disease course.
    Vöglein J; Ricard I; Noachtar S; Kukull WA; Dieterich M; Levin J; Danek A
    J Neurol; 2020 Oct; 267(10):2941-2948. PubMed ID: 32488295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.